Capital Group Private Client Services, Inc. Hutchmed (China) LTD Transaction History

Capital Group Private Client Services, Inc.

  • $9.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.59 - $20.77 $2.15 Million - $5.19 Million
-249,885 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$15.52 - $35.65 $127,108 - $291,973
8,190 Added 3.39%
249,885 $4.73 Million
Q4 2021

Feb 14, 2022
SELL
$28.89 - $35.33 $197,492 - $241,515
-6,836 Reduced 2.75%
241,695 $8.48 Million
Q3 2021

Nov 15, 2021
BUY
$35.66 - $42.94 $8.86 Million - $10.7 Million
248,531 New
248,531 $9.1 Million

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email